**
Overview
Cystic Fibrosis (CF) is a complex, life-threatening disease that affects approximately 70,000 people in the United States and over 75,000 worldwide. It is caused by mutations in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, which codes for a protein responsible for regulating the movement of salt and water in and out of cells. In individuals with CF, the defective protein leads to the production of thick, sticky mucus that clogs the airways, digestive tract, and other organs, causing a range of symptoms and complications.
CF is an autosomal recessive disorder, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition. Carriers of the mutated gene, who have one normal and one mutated copy, are generally asymptomatic but can pass the mutated gene to their offspring. The disease is characterized by a range of symptoms, including persistent coughing, wheezing, and shortness of breath, as well as digestive problems, such as abdominal pain, diarrhea, and malnutrition.
History/Background
Cystic Fibrosis was first described in 1938 by Dr. Dorothy Andersen, an American pathologist who identified the condition as a distinct entity. However, the disease has been recognized for centuries, with descriptions of similar symptoms appearing in ancient medical texts. In the 1950s and 1960s, researchers began to identify the genetic basis of CF, and in 1989, the CFTR gene was cloned, paving the way for the development of genetic testing and targeted therapies.
Key Information
* Symptoms: Persistent coughing, wheezing, and shortness of breath, as well as digestive problems, such as abdominal pain, diarrhea, and malnutrition.
* Causes: Mutations in the CFTR gene, which codes for a protein responsible for regulating the movement of salt and water in and out of cells.
* Complications: Respiratory failure, digestive problems, malnutrition, and reproductive issues.
* Treatment: Medications to thin mucus, antibiotics to treat infections, and lung transplantation in severe cases.
* Prognosis: With proper treatment, individuals with CF can live into their 40s and 50s, but the disease remains a significant cause of morbidity and mortality.
Significance
Cystic Fibrosis is a significant public health concern, with over 75,000 people worldwide affected by the condition. The disease is a major cause of morbidity and mortality, particularly in children and young adults. However, advances in genetic testing, targeted therapies, and lung transplantation have improved the prognosis for individuals with CF, and researchers continue to explore new treatments and potential cures.
INFOBOX:
- Name: Cystic Fibrosis
- Type: Genetic disorder
- Date: 1938 (first described by Dr. Dorothy Andersen)
- Location: Worldwide
- Known For: Being a chronic, life-threatening disease affecting the respiratory, digestive, and reproductive systems.
TAGS: Cystic Fibrosis, CFTR gene, genetic disorder, respiratory disease, digestive disease, reproductive disease, lung transplantation, genetic testing.
